Target intelligence / Profile preview

Helicobacter pylori surface antigens

Molecular classification
Other
01

Overview

Helicobacter pylori surface antigens comprise a diverse set of molecules, including outer membrane proteins (adhesins such as HpaA, BabA, SabA), lipopolysaccharide structures with variable and immunogenic O-antigen motifs, and secreted or peripheral enzymes associated with the bacterial cell surface. These antigens mediate key processes in infection, such as adhesion to gastric epithelial cells, biofilm formation, modulation and evasion of host immune response, and persistence in the stomach environment. The variability of these surface components, driven by phase variation and genetic diversity, underlies H. pylori's ability to colonize and cause chronic infection, and presents both challenges and opportunities for diagnostic and therapeutic targeting. They are key players in the pathogenesis of gastritis, peptic ulcers, and gastric cancer, but the term "surface antigens" is too broad for assignment to a specific structured drug target.

Other names
Surface proteins of Helicobacter pyloriOuter membrane proteins of H. pyloriH. pylori cell surface antigensH. pylori OM antigens
02

Mechanism of action

For candidate vaccines, mechanisms include eliciting antibody response to block adhesion (e.g., HpaA). For lipopolysaccharide antigens, mechanisms involve immune system recognition and activation or subversion.

03

Biological functions

Adhesion to host cellsImmune evasion/modulationTriggering immune responseColonization and persistence in gastric mucosaBiofilm formation
04

Disease associations

InfectionChronic inflammationGastric ulcerGastric cancer
05

Safety considerations

Surface antigen variability and phase variation make them challenging as universal vaccine/drug targetsPotential cross-reactivity and subversion of host immune responses (e.g., via LPS molecular mimicry)
06

Biomarkers

Antibody titers against H. pylori surface antigens may serve as markers of infection or past exposure, but there is no single biomarker for the collective group

Beyond the preview

Go deeper on Helicobacter pylori surface antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori surface antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call